Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
---|---|---|---|---|---|
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0021 | peak area | Wild type | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0023 | peak area | Wild type | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0026 | peak area | Alzheimer’s disease model | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0027 | peak area | Alzheimer’s disease model | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0027 | peak area | Wild type | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0028 | peak area | Alzheimer’s disease model | Saline |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0029 | peak area | Wild type | B. breve MCC1274 |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0030 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0031 | peak area | Wild type | B. breve MCC1274 |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0033 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0036 | peak area | Wild type | B. breve MCC1274 |
Normal phase UNSPECIFIED ION MODE | 5-Oxoproline | 0.0041 | peak area | Alzheimer’s disease model | Saline |